My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 279

    1.

    DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.

    Anglim PP, Alonzo TA, Laird-Offringa IA.

    Mol Cancer. 2008 Oct 23;7:81. Review.PMID: 18947422 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.

    Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, Cozen W, Hagen JA, Koss MN, Laird-Offringa IA.

    Mol Cancer. 2007 Oct 29;6:70.PMID: 17967182 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer.

    Anglim PP, Galler JS, Koss MN, Hagen JA, Turla S, Campan M, Weisenberger DJ, Laird PW, Siegmund KD, Laird-Offringa IA.

    Mol Cancer. 2008 Jul 10;7:62.PMID: 18616821 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.

    Hsu HS, Chen TP, Wen CK, Hung CH, Chen CY, Chen JT, Wang YC.

    J Pathol. 2007 Dec;213(4):412-9.PMID: 17973238 [PubMed - indexed for MEDLINE]Related articles

    5.

    DNA methylation analysis: a powerful new tool for lung cancer diagnosis.

    Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA.

    Oncogene. 2002 Aug 12;21(35):5450-61. Review.PMID: 12154407 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?

    de Fraipont F, Moro-Sibilot D, Michelland S, Brambilla E, Brambilla C, Favrot MC.

    Lung Cancer. 2005 Nov;50(2):199-209. Epub 2005 Jul 25.PMID: 16043258 [PubMed - indexed for MEDLINE]Related articles

    7.

    Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.

    Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, Bianchi L, Rusca M, Mutti A.

    Respir Res. 2005 Jul 14;6:71.PMID: 16018807 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.

    Ehrich M, Field JK, Liloglou T, Xinarianos G, Oeth P, Nelson MR, Cantor CR, van den Boom D.

    Cancer Res. 2006 Nov 15;66(22):10911-8.PMID: 17108128 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.

    Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK, Koss MN, Pass HI, Hagen JA, Laird-Offringa IA.

    Lung Cancer. 2005 Feb;47(2):193-204.PMID: 15639718 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lung cancer epigenetics and genetics.

    Risch A, Plass C.

    Int J Cancer. 2008 Jul 1;123(1):1-7. Review.PMID: 18425819 [PubMed - indexed for MEDLINE]Related articles

    11.

    Methylation-based biomarkers for early detection of urological cancer.

    Henrique R, Costa VL, Jerónimo C.

    Crit Rev Oncog. 2007 Dec;13(4):265-82. Review.PMID: 18540830 [PubMed - indexed for MEDLINE]Related articles

    12.

    Biomarkers for early detection of breast cancer: what, when, and where?

    Levenson VV.

    Biochim Biophys Acta. 2007 Jun;1770(6):847-56. Epub 2007 Feb 12. Review.PMID: 17368950 [PubMed - indexed for MEDLINE]Related articles

    13.

    Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer.

    Suga Y, Miyajima K, Oikawa T, Maeda J, Usuda J, Kajiwara N, Ohira T, Uchida O, Tsuboi M, Hirano T, Kato H, Ikeda N.

    Oncol Rep. 2008 Nov;20(5):1137-42.PMID: 18949413 [PubMed - indexed for MEDLINE]Related articles

    14.

    DNA methylation as a cancer-specific biomarker: from molecules to populations.

    Patel A, Groopman JD, Umar A.

    Ann N Y Acad Sci. 2003 Mar;983:286-97. Review.PMID: 12724233 [PubMed - indexed for MEDLINE]Related articles

    15.

    RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.

    Lin Q, Geng J, Ma K, Yu J, Sun J, Shen Z, Bao G, Chen Y, Zhang H, He Y, Luo X, Feng X, Zhu J.

    J Cancer Res Clin Oncol. 2009 Dec;135(12):1675-84. Epub 2009 Jun 9.PMID: 19506903 [PubMed - indexed for MEDLINE]Related articles

    16.

    Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?

    Bremnes RM, Sirera R, Camps C.

    Lung Cancer. 2005 Jul;49(1):1-12. Review.PMID: 15949585 [PubMed - indexed for MEDLINE]Related articles

    17.

    Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.

    Han W, Wang T, Reilly AA, Keller SM, Spivack SD.

    Respir Res. 2009 Sep 25;10:86.PMID: 19781081 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    DNA methylation changes in prostate cancer: current developments and future clinical implementation.

    Hoque MO.

    Expert Rev Mol Diagn. 2009 Apr;9(3):243-57. Review.PMID: 19379083 [PubMed - indexed for MEDLINE]Related articles

    19.

    Biomarkers for lung cancer: clinical uses.

    Greenberg AK, Lee MS.

    Curr Opin Pulm Med. 2007 Jul;13(4):249-55. Review.PMID: 17534168 [PubMed - indexed for MEDLINE]Related articles

    20.

    Molecular diagnostic markers for lung cancer in sputum and plasma.

    Wang YC, Hsu HS, Chen TP, Chen JT.

    Ann N Y Acad Sci. 2006 Sep;1075:179-84.PMID: 17108209 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk